Monopar Therapeutics Inc.

31.11
-3.48 (-10.06%)
At close: Apr 04, 2025, 12:18 PM

Monopar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
-15.59B -8.4M -10.52M -9.1M -6.3M -4.22M -3.23M -16.55M -1.19M -687.31K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
1.14B 1.9M 1.64M 1.47M 1.32M 1.01M 529.33K 305.2K n/a n/a
n/a -20.41K 167.52K -86.2K -3.79K -47.51K -275.84K -126.78K 298.00 -22.86K
8.04B n/a 162.96K 1.06M -122.4K 767.64K 441.65K 13.5M 9.33K -73.84K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a -1.35M 1.65M 317.77K 443.81K 196.02K -188.16K 120.58K -9.04K 50.98K
-6.4B -7.86M -7.23M -7.32M -4.66M -3.02M -2.89M -2.63M -1.19M -636.33K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-15.32B -7.88M -4.92M n/a n/a n/a n/a n/a n/a n/a
985.73M 12.81M n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a -4.92K n/a n/a n/a n/a n/a n/a n/a
-14.34B 4.93M -4.92M n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a 122.4K n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
59.29B -46.97K -76.46K -45.77K -115.57K -874.81K -206.27K 4.83M n/a 3.44M
59.29B 2.03M 32.87K 10.88M 8.18M 9.35M -206.27K 9.54M 1.26M 3.44M
38.55B -920.11K -12.12M 3.57M 3.52M 6.32M -2.89M 6.91M 67.87K 2.81M
-6.4B -7.86M -7.23M -7.32M -4.66M -3.02M -2.89M -2.63M -1.19M -636.33K